Poison Pill Defense
A defensive measure that dilutes an unwelcome acquirer's stake by letting existing shareholders buy discounted shares once an ownership threshold is crossed.
A poison pill, formally a shareholder rights plan, grants existing shareholders the right to buy additional shares at a steep discount if an acquirer crosses a specified ownership threshold without board approval. Triggering the pill massively dilutes the acquirer's stake, making a hostile takeover economically impractical unless the board redeems or waives the plan, which functionally hands the board significant leverage over any unsolicited approach.
Because a pill is adopted unilaterally by the board and directly affects who can acquire control of the company, it is subject to heightened judicial scrutiny rather than ordinary business judgment deference. Courts typically examine whether the board reasonably perceived a legitimate threat to corporate policy and whether the pill's terms were a proportionate response to that threat, rather than an entrenchment device disguised as a defensive measure.
A pill's real litigation exposure often turns less on its mere existence and more on its specific terms — the trigger threshold, whether it has a 'dead hand' or similar entrenching feature, how long it stays in place. Juricratic models those terms as separate dials feeding into the proportionality analysis, so a user can see which specific feature of a challenged pill is actually driving projected litigation risk.
How it actually shows up
Boards adopt or maintain a poison pill to slow down or block an unsolicited acquisition and preserve leverage to negotiate a better deal or seek alternative bidders. Acquirers and shareholders challenge a pill's adoption or refusal to redeem it as disproportionate or entrenching, arguing the board is using the defense to protect its own position rather than shareholder value.
- What is a poison pill defense?
- It is a shareholder rights plan that lets existing shareholders buy additional shares at a steep discount once an acquirer crosses a set ownership threshold without board approval, diluting the acquirer's stake and deterring a hostile takeover.
- How do courts review a poison pill?
- Courts typically apply heightened scrutiny, asking whether the board reasonably identified a legitimate threat and whether the pill was a proportionate, non-preclusive response to that threat.
- Can shareholders sue over a poison pill?
- Yes — shareholders or a rejected acquirer can challenge the adoption or continued maintenance of a pill as disproportionate to any actual threat or as an entrenchment device that improperly protects the board's own position.
This page is an educational explainer, not legal advice, and creates no attorney–client relationship. Juricratic is a simulation engine: every probability-like figure is a dial you set, not a calibrated prediction. Verify every rule, deadline, and figure against the authorities and orders that govern your matter.
Turn the concept into a modeled matter.
Juricratic makes every one of these ideas a live dial: model your case as a solvable game, then watch the optimal line and the settlement window move as the assumptions do.
Request access →